<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-211-3-5-16</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-2329</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПЕРЕДОВАЯ СТАТЬЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LEADING ARTICLE</subject></subj-group></article-categories><title-group><article-title>Скрининг злокачественных новообразований: состояние проблемы в России и мире</article-title><trans-title-group xml:lang="en"><trans-title>Screening of malignant neoplasms: the state of the problem in Russia and the world</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6581-7017</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ливзан</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Livzan</surname><given-names>M. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4878-0838</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лялюкова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Lyalyukova</surname><given-names>E. A.</given-names></name></name-alternatives><email xlink:type="simple">lyalykova@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-3414-5659</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петросян</surname><given-names>В. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrosian</surname><given-names>V. Yu.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чернышева</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernysheva</surname><given-names>E. N.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Омский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Omsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУЗ «Западно-Сибирский медицинский центр Федерального медико-биологического агентства» России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>West Siberian Medical Center of Federal Biomedical Agency</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования Астраханский государственный медицинский университет Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Astrakhan State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>25</day><month>07</month><year>2023</year></pub-date><volume>0</volume><issue>3</issue><fpage>5</fpage><lpage>16</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ливзан М.А., Лялюкова Е.А., Петросян В.Ю., Чернышева Е.Н., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Ливзан М.А., Лялюкова Е.А., Петросян В.Ю., Чернышева Е.Н.</copyright-holder><copyright-holder xml:lang="en">Livzan M.A., Lyalyukova E.A., Petrosian V.Y., Chernysheva E.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/2329">https://www.nogr.org/jour/article/view/2329</self-uri><abstract><p>Ряд объективных и субъективных причин, таких, как постарение населения, экологические, экономические и другие факторы, определяет тенденцию роста заболеваемости злокачественными новообразованиями во всем мире. По прогнозам GLOBOCAN 2020, в ближайшие годы на рак предстательной железы, легких и бронхов, колоректальный рак будет приходиться почти половина (48%) всех случаев заболевания у мужчин, из них 27% - на рак предстательной железы. У женщин на рак молочной железы, рак легких и колоректальный рак будет приходиться около 51% всех новых диагнозов, при этом только на рак молочной железы - около 30%. В 2021 году Министерством здравоохранения Российской федерации утвержден Порядок проведения профилактических осмотров и диспансеризации, в рамках которого проводятся мероприятия скрининга на раннее выявление онкологических заболеваний, утвержден порядок диспансерного наблюдения определенных групп взрослого населения врачами-специалистами, определены длительность, периодичность диспансерного наблюдения, объем профилактических, диагностических, лечебных и реабилитационных мероприятий. Цель обзора: представить эпидемиологические данные о наиболее частых формах рака в России и мире; действующие рекомендации по организации скрининга и его информативность; мероприятия первичной профилактики.</p></abstract><trans-abstract xml:lang="en"><p>A number of objective and subjective reasons, such as aging of the population, environmental, economic and other factors, determine the trend of increasing incidence of malignant neoplasms worldwide. According to GLOBOCAN 2020 forecasts, in the coming years, prostate, lung and bronchial cancer, colorectal cancer will account for almost half (48%) of all cases of the disease in men, of which 27% are prostate cancer. In women, breast cancer, lung cancer and colorectal cancer will account for about 51% of all new diagnoses, while breast cancer alone will account for about 30%. In 2021, the Ministry of Health of the Russian Federation approved the Procedure for preventive examinations and medical examinations, within the framework of which screening measures for early detection of oncological diseases are carried out, the procedure for dispensary observation of certain groups of the adult population by specialist doctors is approved, the duration, frequency of dispensary observation, the scope of preventive, diagnostic, therapeutic and rehabilitation measures are determined. The aim of the review: to present epidemiological data on the most common forms of cancer in Russia and the world; current recommendations on the organization of screening and its informative value; primary prevention measures.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>скрининг злокачественных образований</kwd><kwd>рак</kwd><kwd>первичная профилактика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>screening of malignancies</kwd><kwd>cancer</kwd><kwd>primary prevention</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660.</mixed-citation><mixed-citation xml:lang="en">Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Yabroff KR, Wu XC, Negoita S, Stevens J, Coyle L, Zhao J, Mumphrey BJ, Jemal A, Ward KC. Association of the COVID-19 Pandemic With Patterns of Statewide Cancer Services. J Natl Cancer Inst. 2022 Jun 13;114(6):907-909. doi: 10.1093/jnci/djab122.</mixed-citation><mixed-citation xml:lang="en">Yabroff KR, Wu XC, Negoita S, Stevens J, Coyle L, Zhao J, Mumphrey BJ, Jemal A, Ward KC. Association of the COVID-19 Pandemic With Patterns of Statewide Cancer Services. J Natl Cancer Inst. 2022 Jun 13;114(6):907-909. doi: 10.1093/jnci/djab122.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kaprin A.D., Starinsky V. V., Shakhzadova A. O. [The state of oncological care for the population of Russia in 2021]. Moscow. MNIOI im. P. A. Herzen - branch of the Federal State Budgetary Institution “NMITs Radiology” of the Ministry of Health of Russia Publ., 2022, 239 P. (in Russ.) ISBN 978-5-85502-275-9.@@ Под ред. А. Д. Каприна, В. В. Старинского, А. О. Шахзадовой Состояние онкологической помощи населению России в 2021 году. - М.: МНИОИ им. П. А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. - илл. - 239 с. ISBN 978-5-85502-275-9.</mixed-citation><mixed-citation xml:lang="en">Kaprin A.D., Starinsky V. V., Shakhzadova A. O. [The state of oncological care for the population of Russia in 2021]. Moscow. MNIOI im. P. A. Herzen - branch of the Federal State Budgetary Institution “NMITs Radiology” of the Ministry of Health of Russia Publ., 2022, 239 P. (in Russ.) ISBN 978-5-85502-275-9.@@ Под ред. А. Д. Каприна, В. В. Старинского, А. О. Шахзадовой Состояние онкологической помощи населению России в 2021 году. - М.: МНИОИ им. П. А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. - илл. - 239 с. ISBN 978-5-85502-275-9.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">[On approval of the Procedure for conducting a preventive medical examination and medical examination of certain groups of the adult population]. Order of the Ministry of Health of Russia (Ministry of Health of the Russian Federation) dated April 27, 2021 No. 404n. (in Russ.)@@ Приказ Минздрава России (Министерство здравоохранения РФ) от 27 апреля 2021 г. № 404н «Об утверждении Порядка проведения профилактического медицинского осмотра и диспансеризации определенных групп взрослого населения»</mixed-citation><mixed-citation xml:lang="en">[On approval of the Procedure for conducting a preventive medical examination and medical examination of certain groups of the adult population]. Order of the Ministry of Health of Russia (Ministry of Health of the Russian Federation) dated April 27, 2021 No. 404n. (in Russ.)@@ Приказ Минздрава России (Министерство здравоохранения РФ) от 27 апреля 2021 г. № 404н «Об утверждении Порядка проведения профилактического медицинского осмотра и диспансеризации определенных групп взрослого населения»</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">[On approval of the procedure for dispensary observation of adults]. Order of the Ministry of Health of Russia dated March 15, 2022 n 168n. (in Russ.)@@ Приказ Минздрава России от 15 марта 2022 г. n 168н «Об утверждении порядка проведения диспансерного наблюдения за взрослыми»</mixed-citation><mixed-citation xml:lang="en">[On approval of the procedure for dispensary observation of adults]. Order of the Ministry of Health of Russia dated March 15, 2022 n 168n. (in Russ.)@@ Приказ Минздрава России от 15 марта 2022 г. n 168н «Об утверждении порядка проведения диспансерного наблюдения за взрослыми»</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Smith R.A., Andrews K. S., Brooks D. et al. Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2018 Jul;68(4):297-316. doi: 10.3322/caac.21446.</mixed-citation><mixed-citation xml:lang="en">Smith R.A., Andrews K. S., Brooks D. et al. Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2018 Jul;68(4):297-316. doi: 10.3322/caac.21446.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">[Malignant neoplasm of the bronchi and lung]. Clinical recommendations of the Ministry of Health of the Russian Federation protocol dated December 25, 2020 No 17-4 / 4884. 2021. (in Russ.)@@ Злокачественное новообразование бронхов и легкого. Клинические рекомендации МЗ РФ протокол от 25.12.2020 No 17-4/4884. 2021.</mixed-citation><mixed-citation xml:lang="en">[Malignant neoplasm of the bronchi and lung]. Clinical recommendations of the Ministry of Health of the Russian Federation protocol dated December 25, 2020 No 17-4 / 4884. 2021. (in Russ.)@@ Злокачественное новообразование бронхов и легкого. Клинические рекомендации МЗ РФ протокол от 25.12.2020 No 17-4/4884. 2021.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Office of the Surgeon General (US); Office on Smoking and Health (US). The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2004. PMID: 20669512.</mixed-citation><mixed-citation xml:lang="en">Office of the Surgeon General (US); Office on Smoking and Health (US). The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2004. PMID: 20669512.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bade B.C., Dela Cruz C. S. Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2020 Mar;41(1):1-24. doi: 10.1016/j.ccm.2019.10.001.</mixed-citation><mixed-citation xml:lang="en">Bade B.C., Dela Cruz C. S. Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2020 Mar;41(1):1-24. doi: 10.1016/j.ccm.2019.10.001.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">[Cancer of the cervix]. Clinical recommendations of the Ministry of Health of the Russian. dec 20 2019. (in Russ.)@@ Клинические рекомендации МЗ РФ. Рак шейки матки. 2020</mixed-citation><mixed-citation xml:lang="en">[Cancer of the cervix]. Clinical recommendations of the Ministry of Health of the Russian. dec 20 2019. (in Russ.)@@ Клинические рекомендации МЗ РФ. Рак шейки матки. 2020</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Simms K.T., Steinberg J., Caruana M., et al. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study. Lancet Oncol. 2019 Mar;20(3):394-407. doi: 10.1016/S1470-2045(18)30836-2.</mixed-citation><mixed-citation xml:lang="en">Simms K.T., Steinberg J., Caruana M., et al. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study. Lancet Oncol. 2019 Mar;20(3):394-407. doi: 10.1016/S1470-2045(18)30836-2.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Howlader N., Noone A. M., Krapcho M., et al. SEER Cancer Statistics Review, 1975-2014. Bethesda, MD: National Cancer Institute; 2017.</mixed-citation><mixed-citation xml:lang="en">Howlader N., Noone A. M., Krapcho M., et al. SEER Cancer Statistics Review, 1975-2014. Bethesda, MD: National Cancer Institute; 2017.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Arbyn M., Weiderpass E., Bruni L., de Sanjosé S., Saraiya M., Ferlay J., Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020 Feb;8(2): e191-e203. doi: 10.1016/S2214-109X(19)30482-6.</mixed-citation><mixed-citation xml:lang="en">Arbyn M., Weiderpass E., Bruni L., de Sanjosé S., Saraiya M., Ferlay J., Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020 Feb;8(2): e191-e203. doi: 10.1016/S2214-109X(19)30482-6.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Morgan E., Arnold M., Camargo M. C. et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study. EClinicalMedicine. 2022 Apr 21;47:101404. doi: 10.1016/j.eclinm.2022.101404.</mixed-citation><mixed-citation xml:lang="en">Morgan E., Arnold M., Camargo M. C. et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study. EClinicalMedicine. 2022 Apr 21;47:101404. doi: 10.1016/j.eclinm.2022.101404.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">[Stomach cancer]. Clinical recommendations of the Ministry of Health of the Russian. 2020. (in Russ.)@@ Клинические рекомендации МЗ РФ. Рак желудка (2021).</mixed-citation><mixed-citation xml:lang="en">[Stomach cancer]. Clinical recommendations of the Ministry of Health of the Russian. 2020. (in Russ.)@@ Клинические рекомендации МЗ РФ. Рак желудка (2021).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">van der Post R. S., Vogelaar I. P., Carneiro F. et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015 Jun;52(6):361-74. doi: 10.1136/jmedgenet-2015-103094.</mixed-citation><mixed-citation xml:lang="en">van der Post R. S., Vogelaar I. P., Carneiro F. et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015 Jun;52(6):361-74. doi: 10.1136/jmedgenet-2015-103094.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Petrovchich I, Ford JM. Genetic predisposition to gastric cancer. Semin Oncol. 2016 Oct;43(5):554-559. doi: 10.1053/j.seminoncol.2016.08.006.</mixed-citation><mixed-citation xml:lang="en">Petrovchich I, Ford JM. Genetic predisposition to gastric cancer. Semin Oncol. 2016 Oct;43(5):554-559. doi: 10.1053/j.seminoncol.2016.08.006.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Poddubnaya I.V., Kaprin A. D., Lyadov V. K. Classification of TNM tumors. 8th ed. Guide and atlas. T. I: Tumors of thoracoabdominal localization. Moscow. Practical medicine, 2018, 424 p. (in Russ.)@@ Поддубная И. В., Каприн А. Д., Лядов В. К. Классификация опухолей TNM. 8-я ред. Руководство и атлас. Т. I: Опухоли торакоабдоминальной локализации. М.; Практическая медицина, 2018. - 424 с.</mixed-citation><mixed-citation xml:lang="en">Poddubnaya I.V., Kaprin A. D., Lyadov V. K. Classification of TNM tumors. 8th ed. Guide and atlas. T. I: Tumors of thoracoabdominal localization. Moscow. Practical medicine, 2018, 424 p. (in Russ.)@@ Поддубная И. В., Каприн А. Д., Лядов В. К. Классификация опухолей TNM. 8-я ред. Руководство и атлас. Т. I: Опухоли торакоабдоминальной локализации. М.; Практическая медицина, 2018. - 424 с.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016 Sep;27(suppl 5): v38-v49. doi: 10.1093/annonc/mdw350.</mixed-citation><mixed-citation xml:lang="en">Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016 Sep;27(suppl 5): v38-v49. doi: 10.1093/annonc/mdw350.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Gastric Cancer Version 2.2019. Available at: https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf (accessed on July 7, 2019).</mixed-citation><mixed-citation xml:lang="en">NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Gastric Cancer Version 2.2019. Available at: https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf (accessed on July 7, 2019).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Bray F., Ferlay J., Soerjomataram I., Siegel R. L., Torre L. A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492.</mixed-citation><mixed-citation xml:lang="en">Bray F., Ferlay J., Soerjomataram I., Siegel R. L., Torre L. A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Dinis-Ribeiro M, Lopes C, da Costa-Pereira A, Guilherme M, Barbosa J, Lomba-Viana H, Silva R, Moreira-Dias L. A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia. J Clin Pathol. 2004 Feb;57(2):177-82. doi: 10.1136/jcp.2003.11270.</mixed-citation><mixed-citation xml:lang="en">Dinis-Ribeiro M, Lopes C, da Costa-Pereira A, Guilherme M, Barbosa J, Lomba-Viana H, Silva R, Moreira-Dias L. A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia. J Clin Pathol. 2004 Feb;57(2):177-82. doi: 10.1136/jcp.2003.11270.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacterand Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019.</mixed-citation><mixed-citation xml:lang="en">Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacterand Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Ivashkin V. T., Maev I. V., Lapina T. L. et al. Clinical Recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on Diagnosis and Treatment of Gastritis and Duodenitis.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021;31(4):70-99. (In Russ.) doi: 10.22416/1382-4376-2021-31-4-70-99.@@ Ивашкин В. Т., Маев И. В., Лапина Т. Л. и соавт. Клинические рекомендации Российской гастроэнтерологической ассоциации и ассоциации «Эндоскопическое общество РЭНДО» по диагностике и лечению гастрита, дуоденита. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2021;31(4):70-99. doi: 10.22416/1382-4376-2021-31-4-70-99.</mixed-citation><mixed-citation xml:lang="en">Ivashkin V. T., Maev I. V., Lapina T. L. et al. Clinical Recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on Diagnosis and Treatment of Gastritis and Duodenitis.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021;31(4):70-99. (In Russ.) doi: 10.22416/1382-4376-2021-31-4-70-99.@@ Ивашкин В. Т., Маев И. В., Лапина Т. Л. и соавт. Клинические рекомендации Российской гастроэнтерологической ассоциации и ассоциации «Эндоскопическое общество РЭНДО» по диагностике и лечению гастрита, дуоденита. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2021;31(4):70-99. doi: 10.22416/1382-4376-2021-31-4-70-99.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Malfertheiner P., Megraud F., Rokkas T., Gisbert J. P., Liou J. M., Schulz C., Gasbarrini A., Hunt R. H., Leja M., O’Morain C., Rugge M., Suerbaum S., Tilg H., Sugano K., El-Omar E.M.; European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022 Aug 8: gutjnl-2022-327745. doi: 10.1136/gutjnl-2022-327745.</mixed-citation><mixed-citation xml:lang="en">Malfertheiner P., Megraud F., Rokkas T., Gisbert J. P., Liou J. M., Schulz C., Gasbarrini A., Hunt R. H., Leja M., O’Morain C., Rugge M., Suerbaum S., Tilg H., Sugano K., El-Omar E.M.; European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022 Aug 8: gutjnl-2022-327745. doi: 10.1136/gutjnl-2022-327745.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Bordin D.S., Livzan M. A. Maastricht VI consensus published: what’s new? Effective pharmacotherapy. 2022; 18(22): 72-84. (in Russ.) doi: 10.33978/2307-3586-2022-18-22-72-84.@@ Бордин Д. С., Ливзан М. А. Консенсус Маастрихт VI опубликован: что нового? Эффективная фармакотерапия. 2022; 18 (22): 72-84. doi: 10.33978/2307-3586-2022-18-22-72-84</mixed-citation><mixed-citation xml:lang="en">Bordin D.S., Livzan M. A. Maastricht VI consensus published: what’s new? Effective pharmacotherapy. 2022; 18(22): 72-84. (in Russ.) doi: 10.33978/2307-3586-2022-18-22-72-84.@@ Бордин Д. С., Ливзан М. А. Консенсус Маастрихт VI опубликован: что нового? Эффективная фармакотерапия. 2022; 18 (22): 72-84. doi: 10.33978/2307-3586-2022-18-22-72-84</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N, Bray F. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023 Feb;72(2):338-344. doi: 10.1136/gutjnl-2022-327736.</mixed-citation><mixed-citation xml:lang="en">Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N, Bray F. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023 Feb;72(2):338-344. doi: 10.1136/gutjnl-2022-327736.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Starostin R.A., Gataullin B. I., Valitov B. R., Gataullin I. G. Colorectal cancer: epidemiology and risk factors. Povolzhsky Oncological Bulletin. 2021;4 (48). (in Russ.) (Available at: https://cyberleninka.ru/article/n/kolorektalnyy-rak-epidemiologiya-i-faktory-riska Access: 01.03.2023)@@ Старостин Р. А., Гатауллин Б. И., Валитов Б. Р., Гатауллин И. Г. Колоректальный рак: эпидемиология и факторы риска. Поволжский онкологический вестник. 2021. № 4 (48). URL: https://cyberleninka.ru/article/n/kolorektalnyy-rak-epidemiologiya-i-faktory-riska (дата обращения: 01.03.2023).</mixed-citation><mixed-citation xml:lang="en">Starostin R.A., Gataullin B. I., Valitov B. R., Gataullin I. G. Colorectal cancer: epidemiology and risk factors. Povolzhsky Oncological Bulletin. 2021;4 (48). (in Russ.) (Available at: https://cyberleninka.ru/article/n/kolorektalnyy-rak-epidemiologiya-i-faktory-riska Access: 01.03.2023)@@ Старостин Р. А., Гатауллин Б. И., Валитов Б. Р., Гатауллин И. Г. Колоректальный рак: эпидемиология и факторы риска. Поволжский онкологический вестник. 2021. № 4 (48). URL: https://cyberleninka.ru/article/n/kolorektalnyy-rak-epidemiologiya-i-faktory-riska (дата обращения: 01.03.2023).</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for Colorectal Cancer: An Evidence Update for the U. S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May. Report No.: 20-05271-EF-1. PMID: 34097369.</mixed-citation><mixed-citation xml:lang="en">Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for Colorectal Cancer: An Evidence Update for the U. S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May. Report No.: 20-05271-EF-1. PMID: 34097369.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">van Leerdam M. E., Roos V. H., van Hooft J. E. et al. Endoscopic management of polyposis syndromes: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2019 Sep;51(9):877-895. doi: 10.1055/a-0965-0605.</mixed-citation><mixed-citation xml:lang="en">van Leerdam M. E., Roos V. H., van Hooft J. E. et al. Endoscopic management of polyposis syndromes: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2019 Sep;51(9):877-895. doi: 10.1055/a-0965-0605.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Song M., Garrett W. S., Chan A. T. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 2015 May;148(6):1244-60.e16. doi: 10.1053/j.gastro.2014.12.035.</mixed-citation><mixed-citation xml:lang="en">Song M., Garrett W. S., Chan A. T. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 2015 May;148(6):1244-60.e16. doi: 10.1053/j.gastro.2014.12.035.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Magalhães B., Peleteiro B., Lunet N. Dietary patterns and colorectal cancer: systematic review and meta-analysis. Eur J Cancer Prev. 2012 Jan;21(1):15-23. doi: 10.1097/CEJ.0b013e3283472241.</mixed-citation><mixed-citation xml:lang="en">Magalhães B., Peleteiro B., Lunet N. Dietary patterns and colorectal cancer: systematic review and meta-analysis. Eur J Cancer Prev. 2012 Jan;21(1):15-23. doi: 10.1097/CEJ.0b013e3283472241.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Arem H., Moore S. C., Park Y., Ballard-Barbash R., Hollenbeck A., Leitzmann M., Matthews C. E. Physical activity and cancer-specific mortality in the NIH-AARP Diet and Health Study cohort.Int J Cancer. 2014 Jul 15; 135(2):423-31. doi: 10.1002/ijc.28659.</mixed-citation><mixed-citation xml:lang="en">Arem H., Moore S. C., Park Y., Ballard-Barbash R., Hollenbeck A., Leitzmann M., Matthews C. E. Physical activity and cancer-specific mortality in the NIH-AARP Diet and Health Study cohort.Int J Cancer. 2014 Jul 15; 135(2):423-31. doi: 10.1002/ijc.28659.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Algra A.M., Rothwell P. M. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 2012 May;13(5):518-27. doi: 10.1016/S1470-2045(12)70112-2.</mixed-citation><mixed-citation xml:lang="en">Algra A.M., Rothwell P. M. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 2012 May;13(5):518-27. doi: 10.1016/S1470-2045(12)70112-2.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">World Gastroenterology Organisation, Practice Guideline - Colorectal cancer screening, 2008.</mixed-citation><mixed-citation xml:lang="en">World Gastroenterology Organisation, Practice Guideline - Colorectal cancer screening, 2008.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Lieberman D. A. Clinical practice. Screening for colorectal cancer. N. Engl. J. Med. 2009; 361(12): 1179-1187. doi: 10.1056/NEJMcp0902176.</mixed-citation><mixed-citation xml:lang="en">Lieberman D. A. Clinical practice. Screening for colorectal cancer. N. Engl. J. Med. 2009; 361(12): 1179-1187. doi: 10.1056/NEJMcp0902176.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Laine L. et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest. Endosc. 2015; 148(3): 639-651.e28. doi: 10.1053/j.gastro.2015.01.031.</mixed-citation><mixed-citation xml:lang="en">Laine L. et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest. Endosc. 2015; 148(3): 639-651.e28. doi: 10.1053/j.gastro.2015.01.031.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Magro F. et al. Third European evidence-based consensus on diagnosis and man. agement of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal mani-festations, pregnancy, cancer surveillance, surgery, and Ileo-anal pouch disorders J. Crohns Colitis. 2017; 11(6): 649-670. doi: 10.1093/ecco-jcc/jjx008.</mixed-citation><mixed-citation xml:lang="en">Magro F. et al. Third European evidence-based consensus on diagnosis and man. agement of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal mani-festations, pregnancy, cancer surveillance, surgery, and Ileo-anal pouch disorders J. Crohns Colitis. 2017; 11(6): 649-670. doi: 10.1093/ecco-jcc/jjx008.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Grossman D.C., Curry S. J., Owens D. K. et al. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710.</mixed-citation><mixed-citation xml:lang="en">Grossman D.C., Curry S. J., Owens D. K. et al. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Stanford J.L., Stephenson R. A., Coyle L. M. et al. Prostate Cancer Trends 1973-1995. SEER Program, National Cancer Institute, NIH Pub.; 99-4543, Bethesda: MD; 1999.</mixed-citation><mixed-citation xml:lang="en">Stanford J.L., Stephenson R. A., Coyle L. M. et al. Prostate Cancer Trends 1973-1995. SEER Program, National Cancer Institute, NIH Pub.; 99-4543, Bethesda: MD; 1999.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate. 1990;17(4):337-47. doi: 10.1002/pros.2990170409.</mixed-citation><mixed-citation xml:lang="en">Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate. 1990;17(4):337-47. doi: 10.1002/pros.2990170409.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Tan D.S., Mok T. S., Rebbeck T. R. Cancer Genomics: Diversity and Disparity Across Ethnicity and Geography. J Clin Oncol. 2016 Jan 1;34(1):91-101. doi: 10.1200/JCO.2015.62.0096.</mixed-citation><mixed-citation xml:lang="en">Tan D.S., Mok T. S., Rebbeck T. R. Cancer Genomics: Diversity and Disparity Across Ethnicity and Geography. J Clin Oncol. 2016 Jan 1;34(1):91-101. doi: 10.1200/JCO.2015.62.0096.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Denis L., Morton M. S., Griffiths K. Diet and its preventive role in prostatic disease. Eur Urol. 1999;35(5-6):377-87. doi: 10.1159/000019912.</mixed-citation><mixed-citation xml:lang="en">Denis L., Morton M. S., Griffiths K. Diet and its preventive role in prostatic disease. Eur Urol. 1999;35(5-6):377-87. doi: 10.1159/000019912.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Catalona W. J. Prostate Cancer Screening. Med Clin North Am. 2018 Mar;102(2):199-214. doi: 10.1016/j.mcna.2017.11.001.</mixed-citation><mixed-citation xml:lang="en">Catalona W. J. Prostate Cancer Screening. Med Clin North Am. 2018 Mar;102(2):199-214. doi: 10.1016/j.mcna.2017.11.001.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Thompson I.M., Ankerst D. P., Chi C., et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst. 2006 Apr 19;98(8):529-34. doi: 10.1093/jnci/djj131.</mixed-citation><mixed-citation xml:lang="en">Thompson I.M., Ankerst D. P., Chi C., et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst. 2006 Apr 19;98(8):529-34. doi: 10.1093/jnci/djj131.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">[Prostate Cancer]. Clinical recommendations of the Ministry of Health of the Russian Federation. 2021. (in Russ.)@@ Клинические рекомендации МЗ РФ. Рак предстательной железы (2021).</mixed-citation><mixed-citation xml:lang="en">[Prostate Cancer]. Clinical recommendations of the Ministry of Health of the Russian Federation. 2021. (in Russ.)@@ Клинические рекомендации МЗ РФ. Рак предстательной железы (2021).</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Lippi G., Mattiuzzi C. Fried food and prostate cancer risk: systematic review and meta-analysis.Int J Food Sci Nutr. 2015;66(5):587-9. doi: 10.3109/09637486.2015.1056111.</mixed-citation><mixed-citation xml:lang="en">Lippi G., Mattiuzzi C. Fried food and prostate cancer risk: systematic review and meta-analysis.Int J Food Sci Nutr. 2015;66(5):587-9. doi: 10.3109/09637486.2015.1056111.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">DeSantis C.E., Bray F., Ferlay J., Lortet-Tieulent J., Anderson B. O., Jemal A.International Variation in Female Breast Cancer Incidence and Mortality Rates. Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1495-506. doi: 10.1158/1055-9965.EPI-15-0535.</mixed-citation><mixed-citation xml:lang="en">DeSantis C.E., Bray F., Ferlay J., Lortet-Tieulent J., Anderson B. O., Jemal A.International Variation in Female Breast Cancer Incidence and Mortality Rates. Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1495-506. doi: 10.1158/1055-9965.EPI-15-0535.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Ginsburg O., Yip C. H., Brooks A. et al. Breast cancer early detection: A phased approach to implementation. Cancer. 2020 May 15;126 Suppl 10(Suppl 10):2379-2393. doi: 10.1002/cncr.32887.</mixed-citation><mixed-citation xml:lang="en">Ginsburg O., Yip C. H., Brooks A. et al. Breast cancer early detection: A phased approach to implementation. Cancer. 2020 May 15;126 Suppl 10(Suppl 10):2379-2393. doi: 10.1002/cncr.32887.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Vysotskaya I. V. Endocrine-sensitive tumors of the reproductive system: a guide for physicians. Moscow. Spec. publishing house med. book. (SIMC). 2014. 126 p. (in Russ.)@@ Высоцкая И. В. Эндокринно-чувствительные опухоли репродуктивной системы: руководство для врачей. М.: Спец. изд-во мед. кн. (СИМК). 2014. 126 с.</mixed-citation><mixed-citation xml:lang="en">Vysotskaya I. V. Endocrine-sensitive tumors of the reproductive system: a guide for physicians. Moscow. Spec. publishing house med. book. (SIMC). 2014. 126 p. (in Russ.)@@ Высоцкая И. В. Эндокринно-чувствительные опухоли репродуктивной системы: руководство для врачей. М.: Спец. изд-во мед. кн. (СИМК). 2014. 126 с.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">[Mammary cancer]. Clinical recommendations of the Ministry of Health of the Russian Federation. 2021. (in Russ.)@@ Клинические рекомендации. Рак молочной железы, 2021</mixed-citation><mixed-citation xml:lang="en">[Mammary cancer]. Clinical recommendations of the Ministry of Health of the Russian Federation. 2021. (in Russ.)@@ Клинические рекомендации. Рак молочной железы, 2021</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Fidler M.M., Gupta S., Soerjomataram I., Ferlay J., Steliarova-Foucher E., Bray F. Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study. Lancet Oncol. 2017 Dec;18(12):1579-1589. doi: 10.1016/S1470-2045(17)30677-0.</mixed-citation><mixed-citation xml:lang="en">Fidler M.M., Gupta S., Soerjomataram I., Ferlay J., Steliarova-Foucher E., Bray F. Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study. Lancet Oncol. 2017 Dec;18(12):1579-1589. doi: 10.1016/S1470-2045(17)30677-0.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
